Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review

May 2021 | 51 pages | ID: A0110ECFFC6EN
GlobalData

Abstracts

Addex Therapeutics Ltd (ADXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Addex Therapeutics Ltd (Addex) is a clinical-stage pharmaceutical company that discovers, develops and commercializes small-molecule pharmaceutical products, including allosteric modulators for neurological disorders. The company develops its proprietary clinical and preclinical-stage drug candidates using its allosteric modulator drug discovery platform. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM) intended to treat Parkinson's disease levodopa-induced dyskinesia. It also carries out clinical and preclinical programs for various indications such as dystonia, epilepsy, post-traumatic stress disorder, addiction and mild neurocognitive and neurodegenerative disorders. The company has collaboration with Janssen Pharmaceuticals, Indivior PLC, government organizations and other academic researchers. Addex is headquartered in Geneva, Switzerland.

Addex Therapeutics Ltd Key Recent Developments

May 14,2021: Addex convenes annual general meeting 2021
May 05,2021: Addex Reports Q1 2021 Financial Results and Provides Corporate Update
Apr 13,2021: Addex to Present at the 20th Annual Needham Virtual Healthcare Conference
Mar 11,2021: Addex Reports Full Year 2020 Financial Results and Provides Corporate Update
Mar 09,2021: Addex Therapeutics to Release Full-Year 2020 Financial Results and Host Conference Call on March 11, 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Addex Therapeutics Ltd - Key Facts
Addex Therapeutics Ltd - Key Employees
Addex Therapeutics Ltd - Key Employee Biographies
Addex Therapeutics Ltd - Major Products and Services
Addex Therapeutics Ltd - History
Addex Therapeutics Ltd - Company Statement
Addex Therapeutics Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Addex Therapeutics Ltd - Business Description
R&D Overview
Addex Therapeutics Ltd - Corporate Strategy
Addex Therapeutics Ltd - SWOT Analysis
SWOT Analysis - Overview
Addex Therapeutics Ltd - Strengths
Addex Therapeutics Ltd - Weaknesses
Addex Therapeutics Ltd - Opportunities
Addex Therapeutics Ltd - Threats
Addex Therapeutics Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Addex Therapeutics Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 14, 2021: Addex convenes annual general meeting 2021
May 05, 2021: Addex Reports Q1 2021 Financial Results and Provides Corporate Update
Apr 13, 2021: Addex to Present at the 20th Annual Needham Virtual Healthcare Conference
Mar 11, 2021: Addex Reports Full Year 2020 Financial Results and Provides Corporate Update
Mar 09, 2021: Addex Therapeutics to Release Full-Year 2020 Financial Results and Host Conference Call on March 11, 2021
Nov 03, 2020: Addex reports Q3 2020 financial results and provides corporate update
Nov 02, 2020: ADDEX THERAPEUTICS TO RELEASE Q3 2020 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 3rd, 2020
Aug 12, 2020: Addex reports 2020 half year financial results and provides corporate update
May 20, 2020: Addex reports Q1 2020 financial results and provides corporate update
May 19, 2020: Addex Therapeutics establishes Scientific Advisory Board

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Addex Therapeutics Ltd, Key Facts
Addex Therapeutics Ltd, Key Employees
Addex Therapeutics Ltd, Key Employee Biographies
Addex Therapeutics Ltd, Major Products and Services
Addex Therapeutics Ltd, History
Addex Therapeutics Ltd, Other Locations
Addex Therapeutics Ltd, Subsidiaries
Addex Therapeutics Ltd, Key Competitors
Addex Therapeutics Ltd, Ratios based on current share price
Addex Therapeutics Ltd, Annual Ratios
Addex Therapeutics Ltd, Annual Ratios (Cont...1)
Addex Therapeutics Ltd, Interim Ratios
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Addex Therapeutics Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Addex Therapeutics Ltd, Performance Chart (2016 - 2020)
Addex Therapeutics Ltd, Ratio Charts
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Addex Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021